In the past months Thomas Goetz begun writing a book on the radical changes already ongoing but mostly upcoming in healthcare due to affordable new technologies and quantitative approaches in personalized genomics and medicine. The book is to be called The Decision Tree (explanation below) accompanied by a new website. Thomas is the perfect man… Continue reading The Decision Tree: Thomas Goetz’s upcoming book on predictive/personalized medicine
This is a golden day for 23andMe despite all crisis worries: Mountain View, CA (PRWEB) October 30, 2008 — TIME Magazine announced today that the Personal Genome Service™ from 23andMe, Inc. has been named 2008’s Invention of the Year. 23andMe was chosen as the year’s most significant invention for its exceptional work in making personal… Continue reading Golden day for 23andMe: Time’s 2008 Invention of the Year
It was time for me to enter personally into the age of commercialized-personalized genetics/genomics and not just to talk about it! New price, new customers! Here is my suggestion to the sales department of 23andMe! 23andMe Democratizes Personal Genomics With New Analytical Platform
It’s my first real encounter with a situation in which the officials of the state of California are clearly against innovation for financial reasons obvious enough (is enough): Wired Science, Alexis Madrigal, upcoming BioBarCamper: Exclusive: DNA Tester Reveals Cease-and-Desist Letter Wired.com has obtained a copy of the cease-and-desist letter sent to Navigenics by the state… Continue reading Innovation stop: “All they’ve done is created an extra billing event for the doctor”
“We really think that we can change Health Care…I want to change it in 5 years…it has to change and that’s we all are about” – says Anne Wojcicki, 23andMe co-founder, in the Google Tech Talk on Googling the Googlers’ DNA: A Demonstration of the 23andMe Personal Genome Service. Also a good presentation by Linda… Continue reading The Sergey, Larry, Eric test by Anne & Linda: 23andMe at home
Consumer-Enabled Research, the second goal of pioneering personalized genetics company 23andMe, reached its first generation with the launch of 23andWe. From BusinessWire: “23andWe marks a new approach to genetics research. By directly involving 23andMe customers in the company’s research projects, the goal is to conduct large-scale studies powered by a web-based community of diverse individuals… Continue reading 23andWe follows 23andMe: First generation of Consumer-Enabled Research
A good introduction in Nature on the risks and advantages of letting people know their genetic risk information via personal genetics services. I do hope that the test-takers will finally become the risk overtakers. Helen Pearson: Genetic testing for everyone Direct-to-consumer genetic testing is a rapidly growing market — the past year has seen the… Continue reading Personal genetics test-takers are future risk-takers
Roni F. Zeiger, MD (watch his presentation), Google Health product manager, whose PubMed profile (if he really is the very same person) gives us a very strong reason why he was hired by Google for this job (he joined Google in 2006). The 38-year-old, who still sees patients some evenings and weekends at a nearby… Continue reading Meet Dr. Google Health: Roni Zeiger, right out of Stanford!